The Skin's Clock Study Behind a Night Serum Ad

A study published this month in the Journal of Investigative Dermatology claims that years of sun exposure do more than wrinkle skin. They scramble its internal clock, dampening the daily rhythm of gene activity and shifting it earlier in the day. The paper, by Shobhan Gaddameedhi and Michael G. Kemp, appears in Volume 146, Issue 10 of JID, but the underlying work was circulating more than a year earlier as a bioRxiv preprint titled "Comparative circadian transcriptome analysis reveals dampened and phase-advanced rhythms in sun-exposed human skin," posted September 30, 2025. The gap between preprint and journal publication is the first thing worth noting: a full year passed between public circulation of the data and formal peer review, during which the findings were already being put to commercial use.

The underlying research, led by scientists at the University of Manchester and the University of Pennsylvania, took paired 3mm punch biopsies from 20 women, aged 51 to 63, with moderate to severe photoageing on their forearms. Researchers sampled sun-exposed forearm skin and sun-protected buttock skin every six hours across a full day, at noon, 6pm, midnight and 6am, then ran RNA sequencing and cosinor analysis to track which genes cycled, how strongly, and when they peaked. According to the University of Manchester's own announcement of the findings, chronic sun exposure left circadian genes in exposed skin oscillating with lower amplitude and peaking earlier than their counterparts in protected skin.

That is a real finding, but a narrow one. All 20 participants were White women in their fifties and sixties with visibly photoaged skin. Nothing in the study design lets it speak to men, to younger skin, to other skin tones, or to people without significant sun damage already present. The buttock skin used as the "protected" comparison was not itself formally scored for photoageing; the researchers assumed it was unaffected rather than testing that assumption. A finding built on 20 biopsied forearms from one demographic slice is evidence of a pattern in that slice, not a general law of human skin.

The study's funding sits awkwardly alongside its promotion. No7 Beauty Company, a commercial skincare brand, co-funded the research, and the company has been using it to market its newly launched Future Renew Night Serum, built on the pitch that skin's "repair window" opens at night. No7's own promotional materials go further than the peer-reviewed data, framing the research as showing that nearly two-thirds of circadian genes in sun-exposed skin peak between 2am and 3am and presenting that as the scientific basis for applying product before bed. The paper itself is a transcriptomic survey of gene expression timing. It does not test whether any serum, No7's or otherwise, changes outcomes when applied at a particular hour. The distance between "genes peak at a certain time" and "therefore buy this product for that time" is exactly the distance a marketing department is paid to erase.

Other recent work suggests why this finding matters mechanistically, even if the JID paper itself cannot prove it. A 2026 British Journal of Dermatology conference abstract, from researchers including Iosifidou, Birch-Machin and O'Connor, exposed human fibroblasts and keratinocytes directly to doses of light equivalent to just 20 minutes of Mediterranean sun. They found an early response in the PER1 and PER2 clock genes, peaking within 6 to 12 hours, followed by a later CLOCK and BMAL1 response peaking at 18 to 24 hours. That cell-level cascade offers a plausible biological route by which sunlight itself could reset the clock machinery the Manchester team measured in whole skin. Both studies, notably, were explicit that most prior circadian-skin research relied on nocturnal rodents, animals whose clocks run on an inverted schedule to diurnal humans, which the newer human-tissue data is only beginning to correct.

The clinical stakes researchers are circling, skin cancer risk tied to circadian disruption, remain unsettled. A review in PMC by Popp and Elston lays out the theoretical case: a disrupted clock could impair the timing of DNA repair after UV damage, weaken immune surveillance in skin, and interfere with melatonin signaling, all plausible contributors to melanoma risk. But the same review describes human evidence, drawn mostly from studies of shift workers, as "modest." The JID paper does not measure cancer outcomes at all. It measures gene expression timing in biopsied tissue from 20 women over 24 hours. Whatever role circadian disruption eventually proves to play in skin cancer, this study is a data point about rhythm, not a verdict about risk, and the two should not be read as the same claim wearing different words.